Table 6.6b

Immunosuppression Used for Maintenance Prior to Discharge, 1993 to 2002

Recipients with Pancreas Transplant Alone (PTA) Transplants

		Year of Transplant
		1993	1994	1995	1996	1997	1998	1999	2000	2001	2002
Functioning Graft at Discharge		40	34	36	45	67	75	126	115	149	164
With Immunosuppression Info		39	34	34	42	66	68	123	113	142	148
Corticosteroids	Category Usage	7.7%	38.2%	20.6%	81.0%	95.5%	97.1%	71.5%	82.3%	81.0%	75.0%
	Steroids	7.7%	38.2%	20.6%	81.0%	95.5%	97.1%	71.5%	82.3%	81.0%	75.0%
Cyclosporine	Category Usage	87.2%	55.9%	35.3%	14.3%	9.1%	5.9%	2.4%	4.4%	4.2%	4.1%
	Cyclosporin	87.2%	55.9%	29.4%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	0.0%	0.0%	0.0%	2.4%	4.5%	1.5%	0.0%	0.0%	1.4%	0.0%
	Neoral	0.0%	0.0%	5.9%	11.9%	4.5%	4.4%	2.4%	4.4%	2.8%	4.1%
Tacrolimus	Category Usage	10.3%	47.1%	58.8%	83.3%	84.8%	92.6%	95.1%	92.0%	93.7%	95.3%
	FK506	10.3%	47.1%	58.8%	83.3%	84.8%	92.6%	95.1%	92.0%	93.7%	95.3%
Antimetabolites	Category Usage	87.2%	100.0%	79.4%	95.2%	93.9%	86.8%	63.4%	69.9%	64.8%	65.5%
	Azathioprine	87.2%	100.0%	61.8%	14.3%	4.5%	5.9%	0.0%	1.8%	0.7%	1.4%
	Mycophenolate mofetil	0.0%	0.0%	17.6%	81.0%	89.4%	83.8%	63.4%	68.1%	64.1%	64.2%
Other	Category Usage	0.0%	0.0%	2.9%	2.4%	0.0%	1.5%	1.6%	8.8%	11.3%	15.5%
	Rapamycin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	1.6%	8.8%	11.3%	15.5%
	Cytoxan	0.0%	0.0%	2.9%	2.4%	0.0%	1.5%	0.0%	0.0%	0.0%	0.0%

Source: OPTN/SRTR Data as of August 1, 2003.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.